Inventor
JOHN P. FISCHER
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
C07DHeterocyclic compounds32%
A61KPreparations for medical, dental or toiletry purposes21%
A61BDiagnosis5%
A61FFilters implantable into blood vessels5%
H05KPrinted circuits5%
PatentTitleYear
12,351,581Compounds for FGFR inhibition202511,932,633KRas G12C inhibitors202411,884,664Protein tyrosine phosphatase inhibitors202411,648,001Mechanical mesh fixation device and curvilinear tack system202311,634,417Protein tyrosine phosphatase inhibitors202311,548,888KRas G12C inhibitors202311,267,812KRAS G12C inhibitors2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to ARRAY BIOPHARMA INC (5)· patent assignee history
2022–2024Patents assigned to MIRATI THERAPEUTICS INC (3)· patent assignee history
2022–2025Based in US· patent location history
2023Patents assigned to UNIV PENNSYLVANIA (1)· patent assignee history
2025Patents assigned to COGENT BIOSCIENCES INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ARRAY BIOPHARMA INC | 5 | 2022–2024 |
| MIRATI THERAPEUTICS INC | 3 | 2022–2024 |
| COGENT BIOSCIENCES INC | 1 | 2025 |
| UNIV PENNSYLVANIA | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2022–2025 |